Le Lézard
Classified in: Health, Business, Sports and recreation
Subjects: CSR, AVO

Canadians raise $17 million at the Canadian Cancer Society CIBC Run for the Cure


Funds raised benefit breast cancer research and the country's largest support system for people facing breast cancer

TORONTO, Oct. 6, 2019 /CNW/ - Today, 85,000 Canadians laced up their shoes in 57 communities across the country to take part in the Canadian Cancer Society CIBC Run for the Cure, raising $17 million to support the breast cancer cause.

Today, 85,000 people across the country united to raise $17 million for breast cancer at the Canadian Cancer Society CIBC Run for the Cure. (CNW Group/Canadian Cancer Society)

Funds raised will help the Canadian Cancer Society (CCS) continue to benefit the best breast cancer research in Canada, as well as our vitally important support system that helps people better manage life with cancer, provides community and connection and builds wellness and resilience throughout the cancer journey. These programs, such as our national, toll-free helpline and peer support, help people with breast cancer live their lives as fully as possible.

"Since the Run began in 1992, it has raised $462 million for the breast cancer cause," says Andrea Seale, CEO, CCS. "It's because of the funds Canadians raise through the CIBC Run for the Cure that we know more than ever how to prevent, diagnose, treat and live with and beyond breast cancer, and have been able to help reduce the mortality rate by almost half since it peaked in 1986."

The Canadian Cancer Society CIBC Run for the Cure is a trailblazing partnership between CCS, CIBC and communities across Canada. This year's Run marked CIBC's 23rd year as title sponsor. Together with tens of thousands of participants and supporters across the country, the Run has created a movement that brings Canadians together in support of friends, family and loved ones who experience breast cancer.

"Today was another incredible day for thousands of Canadians as we came together with shared purpose to imagine a future without breast cancer," said Christina Kramer, CIBC's Senior Executive Vice-President and Executive Run Sponsor, CIBC. "Team CIBC has proudly run alongside those affected by breast cancer for 23 years because for us, this is personal."

"For more than two decades, Team CIBC and its 44,000 passionate team members have been supporting events like the Canadian Cancer Society CIBC Run for the Cure," says Seale. "We are so grateful to Team CIBC for joining us once again this year and promising to make breast cancer beatable. Along with participants and volunteers from coast-to-coast, together, we are a force-for-life in the face of breast cancer."

The first CIBC Run for the Cure took place in 1992 in Toronto's High Park. A group of volunteers brought together approximately 1,500 people and raised $85,000 for the breast cancer cause. Since then, the event has grown and each year unites thousands of Canadians.

About the Canadian Cancer Society CIBC Run for the Cure
The Canadian Cancer Society CIBC Run for the Cure is the largest, single-day, volunteer-led event dedicated to raising funds for the breast cancer cause. On October 6, 2019, this national movement brought together 85,000 participants and raised $17 million in communities across Canada. Since the event began in 1992, the CIBC Run for the Cure has raised more than $462 million for breast cancer research and support. Donate or learn more at www.cibcrunforthecure.com.

About the Canadian Cancer Society
The Canadian Cancer Society is a national community-based organization whose mission is the eradication of cancer and the enhancement of the quality of life of people living with cancer. When you want to know more about cancer, visit our website www.cancer.ca or call our toll-free, bilingual Cancer Information Service at 1 888 939-3333.

CIBC in the community 
CIBC is a leading North American financial institution with 10 million personal banking, business, public sector and institutional clients. United under the bank's community investment brand One for Change, CIBC and its team are committed to coming together to support people and communities with the belief that giving is personal and comes from the heart. Corporately, CIBC is focused on making a difference for those affected by cancer, as well as supporting persons with disabilities; in the U.S., CIBC focuses its investments in financial literacy. In 2018, CIBC and its team invested $80 million in community organizations across Canada and the U.S., through initiatives that include the Canadian Cancer Society CIBC Run for the Cure and CIBC Miracle Day. Learn more about community investment online or join the #OneforChange conversation on Twitter @CIBC and Facebook (www.facebook.com/CIBC) or follow on Instagram @CIBC.

A father and daughter support their wife/mom (centre), a breast cancer survivor, at the Canadian Cancer Society CIBC Run for the Cure. (CNW Group/Canadian Cancer Society)

SOURCE Canadian Cancer Society


These press releases may also interest you

at 07:15
IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the "Company" or "IPA") , InterSystems, a creative data technology provider dedicated to helping customers solve their most critical scalability, interoperability, and speed challenges, together with ImmunoPrecise...

at 07:10
Can-Fite BioPharma Ltd. , a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases, today announced financial results and clinical updates for the twelve months ended...

at 07:10
Kelonia Therapeutics, a biotech company revolutionizing in vivo gene delivery, today announced the appointments of global leaders in cell therapy and drug development, Kristen Hege, M.D., and Mathai Mammen, M.D., Ph.D., to its board of directors....

at 07:05
Aldeyra Therapeutics, Inc. (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated and metabolic diseases, today announced the clinical development plan intended to enable...

at 07:05
Mythic Therapeutics, a clinical-stage biotechnology company committed to the development of next-generation antibody-drug conjugate (ADC) therapies for the treatment of a wide range of cancers, announced that George Eliades, Ph.D., has joined the...

at 07:05
Seres Therapeutics, Inc. ("Seres" or the "Company"), a leading microbiome therapeutics company, today announced that on March 25, 2024, the Compensation and Talent Committee of Seres' board of directors granted inducement equity grants covering an...



News published on and distributed by: